Clinical Trials Directory

Trials / Unknown

UnknownNCT05577871

Dexmedetomidine in Off Pump Coronary Artery Bypass Grafting

Echocardiographic Evaluation of the Effect of Dexmedetomidine Infusion as an Adjuvant to General Anesthesia in Off-pump Coronary Artery Bypass Grafting

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
36 (estimated)
Sponsor
Suez Canal University · Academic / Other
Sex
All
Age
21 Years – 60 Years
Healthy volunteers
Not accepted

Summary

the study will assess the impact of intraoperative dexmedetomidine infusion on myocardial performance by investigating the left ventricular (LV) systolic and diastolic function and right ventricular (RV) fraction area change (which reflect RV systolic function) using two-dimensional trans-esophageal echocardiography (TEE) in patients undergoing elective first-time isolated off-pump coronary artery bypass (OPCAB) grafting. LV Systolic function will be measured by the TEE via the fractional area change, fraction shortening, and ejection fraction.

Detailed description

Off pump coronary revascularization is an old technique performed first in St Petersburg in 1964, Off pump coronary artery surgery has been developed following two different approaches. Minimally invasive direct-access coronary artery bypass (MIDCAB) that consists of anastomosing the left internal mammary artery to the left anterior descending coronary artery through small anterior left thoracotomy, The second approach is multi-vessel grafting without CPB performed through standard median sternotomy. Dexmedetomidine (Dex), a highly selective α2-adrenergic receptor agonist, is widely used for sedation and analgesia in the ICU or as an anesthetic adjuvant. This study will be a prospective comparative controlled randomized double blinded clinical trial on 36 patients divided into control ,and dexmedetomidine group.

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidineinfusion of dexmedetomidine during the off pump coronary artery bypass grafting surgery
DRUGnormal salineinfusion of normal saline during the off pump coronary artery bypass grafting surgery

Timeline

Start date
2022-11-01
Primary completion
2023-02-28
Completion
2023-03-30
First posted
2022-10-13
Last updated
2022-10-13

Source: ClinicalTrials.gov record NCT05577871. Inclusion in this directory is not an endorsement.